BTG PLC | 4,274 Euro | +0,172 +4,19 % | |
| WKN: 908827 ISIN: GB0001001592 Ticker-Symbol: B9M | Frankfurt | 17.05.13 | 13:06 Uhr |
Branche PharmaAktienmarkt FTSE-250FTSE techMARK Focus |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 08.05. | Brazil's BTG Pactual is easing dependence on trading, CEO says | - | Reuters.com | |
| 08.05. | UPDATE 1-Brazil's BTG Pactual misses profit estimates as expenses soar | - | Reuters.com | |
| 08.05. | BTG Pactual Announces Its First Quarter 2013 Results | 79 | PR Newswire | |
| RIO DE JANEIRO, May 7, 2013 /PRNewswire/ -- Banco BTG Pactual S.A. ("Banco BTG Pactual") and BTG Pactual Participations Ltd. ("BTGP", and together with Banco BTG Pactual and their respective subsidiaries... Mehr lesen zu: BTG Pactual Announces Its First Quarter 2013 Results | ||||
| 08.05. | Brazil's BTG Pactual misses profit estimates as expenses soar | - | Reuters.com | |
| 30.04. | BTG PLC: Total Voting Rights | - | InvestEgate | |
| 15.04. | BTG PLC: Holding(s) in Company | - | InvestEgate | |
| 12.04. | BTG varicose vein treatment accepted for review by FDA | 3 | ShareCast | |
| 12.04. | UPDATE 1-BTG vein treatment on track for potential 2014 launch | - | Reuters.com | |
| 12.04. | BTG's Varisolve accepted for full review by FDA | 1 | StockMarketWire | |
| 12.04. | BTG Says Varisolve NDA Accepted For Full Review By FDA | 70 | AFX News | |
| LONDON (dpa-AFX) - BTG plc (BTG.L), the specialist healthcare company,
announced that the New Drug Application or NDA seeking approval of Varisolve as
a comprehensive treatment for varicose... Mehr lesen zu: BTG Says Varisolve NDA Accepted For Full Review By FDA | ||||
| 12.04. | BTG PLC: Varisolve£ NDA accepted for full review by FDA | - | InvestEgate | |
| 05.04. | Friday tips round-up: AMEC, BTG, Heritage Oil | 9 | ShareCast | |
| 05.04. | BTG Said to Seek Portugal, Spain Assets: Corporate Brazil | - | Bloomberg | |
| 04.04. | Why AMEC, BTG, and Domino's Pizza Group Should Beat the FTSE 100 Today | 1 | Motley Fool | |
| 04.04. | BTG revises annual revenue forecast higher | - | ShareCast | |
| 04.04. | BTG Says Delivered Strong Financial Performance; Sees FY Revenue To Be £230 Mln | 76 | AFX News | |
| LONDON (dpa-AFX) - Specialist healthcare company BTG plc (BTG) said, in an
update for the year ended 31 March 2013, that the group has delivered a strong
financial performance and has achieved... Mehr lesen zu: BTG Says Delivered Strong Financial Performance; Sees FY Revenue To Be £230 Mln | ||||
| 04.04. | BTG achieved key business objectives | - | StockMarketWire | |
| 04.04. | BTG PLC: Close period update | - | InvestEgate | |
| 03.04. | FINEWS LATAM-BTG Pactual unit to sell five-year debt -sources | - | Reuters.com | |
| 02.04. | BTG PLC: Blocklisting Interim Review | 1 | InvestEgate | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| GUERBET | 94,67 | -0,55 % | Medical Imaging Drugs Advisory Committee Recommends Approval of Guerbet NDA for Dotarem (gadoterate meglumine) |
| PHARMAXIS | 0,108 | +6,93 % | PHARMAXIS LTD: Ceasing to be a substantial holder |
| GRIFOLS | 29,012 | -0,06 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 11.12.2012 - 1 |
| IPSEN | 27,245 | -0,83 % | Ipsen : Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company |
| BOIRON | 41,711 | -1,39 % | BOIRON: 2013 first quarter activity |
